News on BioArtificial Gel Technologies from BioPortfolio.com http://www.BioPortfolio.com Consolidated BioArtificial Gel Technologies news from BioPortfolio.com Wed, 10 Feb 2010 11:01:07 GMT en Living Cell Technologies swaps license for portion of US companyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039263&HITNO=0&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039263&THISHREF=http://c.moreover.com/click/here.pl%3fz2537990667%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039263&HITNO=0&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039263&THISHREF=http://c.moreover.com/click/here.pl%3fz2537990667%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAustralian Life Scientist: Spotlight on oral carehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039156&HITNO=1&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039156&THISHREF=http://c.moreover.com/click/here.pl%3fz2537961474%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039156&HITNO=1&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039156&THISHREF=http://c.moreover.com/click/here.pl%3fz2537961474%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comModern Medicine: Johnson & Johnson-Skincare - Body-Gel Baby Oil (4 lippies, 118 reviews)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039519&HITNO=2&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039519&THISHREF=http://c.moreover.com/click/here.pl%3fz2538182295%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039519&HITNO=2&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039519&THISHREF=http://c.moreover.com/click/here.pl%3fz2538182295%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMakeupalley: Johnson & Johnson-Skincare - Body-Gel Baby Oil (4 lippies, 117 reviews)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039036&HITNO=3&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039036&THISHREF=http://c.moreover.com/click/here.pl%3fz2537885513%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039036&HITNO=3&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039036&THISHREF=http://c.moreover.com/click/here.pl%3fz2537885513%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMakeupalley: Breast enhancement surgery: Pros, cons and optionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040862&HITNO=4&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040862&THISHREF=http://c.moreover.com/click/here.pl%3fz2538908190%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040862&HITNO=4&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040862&THISHREF=http://c.moreover.com/click/here.pl%3fz2538908190%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Agennix AG Announces U.S. Class Action Lawsuit Against Predecessor GPC Biotech AG Fully Closedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040991&HITNO=5&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040991&THISHREF=http://c.moreover.com/click/here.pl%3fz2538958378%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040991&HITNO=5&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040991&THISHREF=http://c.moreover.com/click/here.pl%3fz2538958378%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Agennix AG Announces U.S. Class Action Lawsuit Against Predecessor GPC Biotech AG Fully Closedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040917&HITNO=6&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040917&THISHREF=http://c.moreover.com/click/here.pl%3fz2538919831%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040917&HITNO=6&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040917&THISHREF=http://c.moreover.com/click/here.pl%3fz2538919831%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Agennix AG Announces U.S. Class Action Lawsuit Against Predecessor GPC Biotech AG Fully Closed Court Rejects Request to File ..http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040769&HITNO=7&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040769&THISHREF=http://c.moreover.com/click/here.pl%3fz2538862400%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040769&HITNO=7&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040769&THISHREF=http://c.moreover.com/click/here.pl%3fz2538862400%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Agennix AG Announces U.S. Class Action Lawsuit Against Predecessor GPC Biotech AG Fully Closed Courthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040768&HITNO=8&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040768&THISHREF=http://c.moreover.com/click/here.pl%3fz2538862119%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040768&HITNO=8&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040768&THISHREF=http://c.moreover.com/click/here.pl%3fz2538862119%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Agennix AG Announces U.S. Class Action Lawsuit Against Predecessor GPC Biotech AG Fully Closedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040677&HITNO=9&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040677&THISHREF=http://c.moreover.com/click/here.pl%3fz2538830959%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040677&HITNO=9&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040677&THISHREF=http://c.moreover.com/click/here.pl%3fz2538830959%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Agennix AG Announces U.S. Class Action Lawsuit Against Predecessor GPC Biotech AG Fully Closedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040666&HITNO=10&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040666&THISHREF=http://c.moreover.com/click/here.pl%3fz2538827150%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040666&HITNO=10&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040666&THISHREF=http://c.moreover.com/click/here.pl%3fz2538827150%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSys-Con Canada: Agennix AG Announces U.S. Class Action Lawsuit Against Predecessor GPC Biotech AG Fully Closedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040598&HITNO=11&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040598&THISHREF=http://c.moreover.com/click/here.pl%3fz2538804789%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040598&HITNO=11&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040598&THISHREF=http://c.moreover.com/click/here.pl%3fz2538804789%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockhouse Canada: Agennix AG Announces U.S. Class Action Lawsuit Against Predecessor GPC Biotech AG Fully Closedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040560&HITNO=12&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040560&THISHREF=http://c.moreover.com/click/here.pl%3fz2538792600%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040560&HITNO=12&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040560&THISHREF=http://c.moreover.com/click/here.pl%3fz2538792600%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Agennix AG Announces U.S. Class Action Lawsuit Against Predecessor GPC Biotech AG Fully Closedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040553&HITNO=13&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040553&THISHREF=http://c.moreover.com/click/here.pl%3fz2538790854%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040553&HITNO=13&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040553&THISHREF=http://c.moreover.com/click/here.pl%3fz2538790854%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockHouse USA: Agennix AG Announces U.S. Class Action Lawsuit Against Predecessor GPC Biotech AG Fully Closedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040551&HITNO=14&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040551&THISHREF=http://c.moreover.com/click/here.pl%3fz2538790734%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040551&HITNO=14&MSIZE=990&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioArtificial%20Gel%20Technologies&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040551&THISHREF=http://c.moreover.com/click/here.pl%3fz2538790734%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockHouse USA: